newsfilter
← Latest News
GlobeNewswire·

Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update

BOSTON and LOUISVILLE, Ky., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (NASDAQ:TALS), a late-clinical stage cell therapy company developing therapies with the potential to transform the standard of care in solid organ transplantation,